Neurodevelopmental clinic software: a 2026 buyer's guide

The best software for an ADHD and autism clinic in the UK depends on the shape of your service, not a feature list. This guide compares the realistic options (Semble and Pabau, Cliniko and WriteUpp, AI scribes such as Heidi Health and Accurx Scribe, generic EHRs such as EMIS and SystmOne, and Cerebric) and how to run the evaluation.

Start with the shape of your service, not the feature list

A neurodevelopmental assessment pathway is unusually long for outpatient care. A single ADHD or autism referral can involve triage and screening, parent, teacher or partner questionnaires, a multi-part clinical interview, ADOS-2 and ADI-R sessions coordinated across clinicians, a diagnostic report that runs to many pages, a GP letter, and months of titration follow-up. The adult ADHD assessment quality assurance standard (AQAS), published by UKAAN clinicians in Frontiers in Psychiatry, recommends two hours or more for an adequate diagnostic assessment alone, before any of the surrounding administration.

A neurodevelopmental assessment pathwayReferral inScreening triagePatient & informant questionnairesself / parent / teacher / GPDiagnostic appointmentsADOS-2 and ADI-RCited draft reportPayer reporting and titrationWhere a case can stall: each hand-off is a point of failure.

That pathway shape is why software choices diverge. Most clinic software is built around a consultation: book it, document it, bill it. Neurodevelopmental work is built around a journey with several hand-offs, and each hand-off is somewhere a case can stall. So before comparing products, answer three questions. Is assessment your core business or one service line among many? How is the work funded: privately, through NHS Right to Choose, under a block contract, or some mix of the three? And is your bottleneck documentation time, or the whole pipeline from referral to signed report?

Your answers point to different categories of tool. If your core business is UK ADHD and autism assessment, Cerebric is built for the whole pathway; the other categories suit different shapes of service. Here are the realistic options, described from their own public materials.

Semble

Semble is a UK clinic management platform that brings electronic records, scheduling, billing, telehealth, patient communications and analytics into one system. It is built to serve any specialty rather than a particular one, with an automation layer for wiring in external tools and a CQC toolkit for inspection readiness. It does not publish pricing: subscriptions are quoted per practitioner on request, with the Heidi AI scribe, SMS and payment processing charged as extras.

Strengths: breadth and maturity. If you run a multi-specialty private clinic where neurodevelopmental work sits alongside dermatology or physiotherapy, one system for the whole business is a sensible default, and Semble's operational core is well established in UK private healthcare.

The trade-off: it is specialty-agnostic. Patient and informant questionnaire scoring, ADOS and ADI-R session bundling, diagnostic report drafting and payer-split reporting are not in its published toolkit. Its scheduling books appointments rather than pathways: it will not enforce the order sessions must happen in, match a session to the clinicians qualified for it, or hold the room it needs. An assessment service would build those workflows itself from generic forms and integrations: workable, but the assembly and its upkeep become your project. Fuller analysis in Semble for ADHD and autism clinics, and a direct Semble vs Cerebric comparison.

Pabau

Pabau is a UK all-in-one in the same generalist bracket as Semble, sold across a broad range of private clinics (aesthetics, dermatology, private GP, physiotherapy and beyond). It brings records, scheduling, payments, telehealth and marketing into one system, bills UK private insurers through Healthcode, and leans harder into built-in AI than most of its peers, offering a scribe, a prescribing safety-check agent and a letters generator. Only single-user plans are priced publicly, at around £49 per month for a solo practitioner; anything larger is quoted on request, and AI, SMS, telehealth and card terminals are billed as credits (£0.10 each) on top of the subscription.

Strengths: breadth with AI built in. For a multi-specialty private clinic that wants one system and values native AI drafting alongside private-insurance billing, Pabau is a mature, capable choice.

The trade-off is Semble's. It is specialty-agnostic: informant scoring, ADOS/ADI-R coordination and payer-split reporting are not in the toolkit, so an assessment service would assemble them itself. And its AI is consultation-shaped, drafting from a session rather than synthesising a multi-source diagnostic report with per-claim evidence links.

Cliniko

Cliniko is an Australian practice-management platform that has been running since 2011, which makes it one of the more established tools in the category. It is aimed at allied health and therapy-led practices, and it covers the practice-management basics well (scheduling, online booking, intake forms, treatment notes, telehealth, invoicing and card payments), with reconciliation handled through a Xero integration. UK accounts have their data stored in the UK, and pricing is simple and keen: billed in US dollars per clinic by practitioner band, from $45 a month for a single practitioner and $95 for two to five, with every feature included and no contract.

Strengths: it is affordable, and it is simple. That is the pitch, and for a small allied health or therapy-led practice it is a perfectly respectable one. Where Semble sells breadth and clinical depth, Cliniko sells a tidy, no-frills core at a budget-friendly price. If scheduling, notes and billing in one place is genuinely all you need, you will not feel short-changed.

The trade-offs mirror Semble's, plus two of its own. Like Semble, it is specialty-agnostic: informant scoring, ADOS/ADI-R bundling and payer-split reporting aren't in the toolkit. Beyond that, Cliniko has no AI of its own; note drafting comes from third-party scribe integrations (Heidi and similar) that are scribe-shaped, drafting from a single session rather than synthesising a multi-source diagnostic report with per-claim evidence links. And while UK data residency and GDPR are covered, its materials carry none of the NHS-specific evidence you will need for NHS-adjacent work (a completed DTAC, a DCB0129 safety case, DSPT registration); the ISO 27001 and PCI DSS badges on its security page belong to AWS and Stripe, its hosting and payment suppliers, rather than to Cliniko itself.

WriteUpp

WriteUpp is a UK-native practice-management tool for therapists, counsellors and allied health, in the same lean bracket as Cliniko. It covers scheduling, clinical notes, online booking, invoicing and telehealth, with UK data hosting, ISO 27001 certification and UK-based support, and pricing from £19.95 per user per month on the pay-as-you-go Flex plan, £27.95 for Solo or £45.95 for a two-clinician Group account (further users £12 to £15 each). It has recently added an AI medical scribe, sold as a £23.95 per user per month add-on.

Strengths: budget-friendly, simple and reassuringly British. At £20 to £28 a head it sits at the budget end of the shelf, and to its credit it is honest about that: a solo therapist or small practice gets a straightforward, UK-hosted system without paying for capabilities they were never going to touch. It does the essentials tidily, and does not pretend to be more than an entry-level tool. Do the sum with the scribe switched on, though: at £23.95 per user it more than doubles the cost of a Flex seat.

The trade-offs match Cliniko's. It is specialty-agnostic, so informant scoring, ADOS/ADI-R bundling and payer reporting sit outside it; its scheduling is a diary rather than a pathway; and its scribe drafts a consultation note rather than an assessment report with per-claim citations.

AI scribes: Heidi Health and Accurx Scribe

An AI scribe listens to a consultation and drafts the clinical note. Heidi Health transcribes encounters and generates notes from templates. Accurx Scribe, powered by Tandem Health, is rolling out across the Accurx platform; Accurx reports documentation time falling from around seven minutes to just over one per appointment and states that Scribe meets NHS England's requirements for AI scribe technology.

For the job they were built for, these tools work well. That job is the GP-style consultation: a short appointment that needs a quick, accurate summary note, repeated dozens of times a day. Accurx's seven-minutes-to-one metric describes exactly that world, and for a single clinician whose only pain is documentation, a scribe is the right first move, quick to adopt and a real time-saver.

A neurodevelopmental assessment is a different shape of encounter, and it exposes two limits.

• A summary is not a report. The clinical interview alone runs to two hours or more under AQAS guidance, and the output is a diagnostic report of many pages that synthesises the interview with informant questionnaires, school records and developmental history, written in neuro-affirming language for the patient and family to read and live with. Scribe summaries are pitched at consultation length and often are not detailed enough to carry that weight; you end up rewriting rather than editing.
• No citations means the time saved comes back as verification. A scribe drafts prose without tracing each statement to its source, so the hours it saves on typing return as hours spent checking every claim against the transcript, questionnaires and records before you can sign. A platform that links each sentence to its evidence lets you verify in place instead.

A scribe only ever hears the interview, so patient and informant questionnaires, scheduling, structured reports and NHS submission reporting are simply not its category, and neither product claims otherwise. We unpack this in AI scribes vs assessment platforms, and what the reporting style demands in neuro-affirming ADHD and autism reports.

Generic EHRs and spreadsheets

Plenty of UK assessment services run on a generic EHR plus spreadsheets, email and shared drives. In fairness: it is cheap, familiar, and perfectly serviceable at low volume. If you assess a handful of patients a month, disciplined spreadsheets may genuinely be the right answer this year.

The best-known UK EHRs are the NHS primary-care systems: EMIS Web (from EMIS Health, now part of Optum) and SystmOne (from TPP), which between them are used by more than 90% of English GP practices. They are built around the GP consultation and the NHS primary-care contract, which is a different job from running an assessment pathway: nothing in them is shaped around informant questionnaires, ADOS/ADI-R coordination or a cited diagnostic report. Their private tiers (such as EMIS Web Clinical Services) also carry NHS licensing and network hurdles that make them an awkward fit for an independent assessment clinic, and they still do not touch the assessment workflow. So most private services end up on a lighter records tool plus spreadsheets rather than on EMIS itself.

Whatever the base system, the problems arrive with growth. Questionnaire chasing, hand-scoring, report version control and payer reporting all live in someone's inbox, so admin headcount scales with referrals. Audit evidence (who saw what, when, and why) is scattered across systems, which makes CQC preparation and clinical governance slower than it should be.

Cerebric

Cerebric is a vertical platform built for one job: running UK ADHD and autism assessment services end to end. In practice that means:

• Intake and screening: patients self-register and are screened by rules that flag cases for clinician review.
• Patient and informant questionnaires: patient self-report forms plus parent, teacher and GP questionnaires are sent, chased and scored automatically on submission, with the results written to the record rather than transcribed by hand.
• Patient communication: secure messaging with patients and families in the portal, so correspondence sits on the record instead of in a clinician's inbox.
• Scheduling: pathway-aware rather than diary-based. It enforces the order sessions must happen in, matches each one to clinicians who are qualified and actually free, coordinates multi-clinician ADOS-2 and ADI-R bundles, books at room level, and handles patient self-booking, automatic video links and DNA tracking.
• Payments and payer models: private self-pay, NHS Right to Choose and NHS block contracts run side by side in one service, with billing and reconciliation across multiple payment providers and accounting platforms.
• Reports: assessments are recorded and transcribed, and diagnostic reports are AI-drafted from clinic-configurable templates in which every sentence is traceable to its source (a transcript timestamp, questionnaire answer or document) and verified by the clinician before approval.
• Analytics: reporting split by payer type (private, Right to Choose, block contract) with CSV export for NHS submissions.

On compliance, Cerebric is a registered UKCA Class I medical device, holds NHS DSPT (Standards Exceeded) and DTAC, and operates a DCB0129 clinical safety process.

The measured effect is on throughput: clinicians completed 58% more assessments, and report drafting fell from roughly two hours to under 30 minutes. Measured across Cerebric pilot deployments at UK Right to Choose and private neurodevelopmental providers, 2025–26. Adoption has not been the fight some leaders expect: "My biggest fear was clinicians hating it. It was the complete opposite: they're emailing me asking when we're going to deploy it," as the Clinical Lead of one Right to Choose provider put it.

Cerebric is built for UK services whose core business is neurodevelopmental assessment, including smaller clinics that plan to scale, and it does not assume a particular funding model: private-only, NHS-only and mixed-payer services all run on it. It is the wrong choice for a general practice or multi-specialty clinic, or for a single clinician who only wants dictation. Nothing in it is limited to ADHD and autism, so services that run wider mental health work alongside their assessment pathway are not fenced out of it, but the assessment pathway is what it is built and optimised for. It works standalone or alongside an existing EHR via a Chrome extension, so it does not force a records migration.

The coverage table below shows what each category actually covers across the pathway. States read Native (built in), Build it yourself (assemble from generic forms and integrations), Manual, or Not its category.

Which option to choose

The table below is about who should choose each option.

How to run the evaluation

Run every demo against your own pathway, not the vendor's script. Pick one real (anonymised) case (say, a Right to Choose adult ADHD referral) and ask the vendor to walk it from referral letter to signed report and GP letter. Useful questions to press on:

• Which steps are native, which are integrations, and which are roadmap?
• How are patient and informant questionnaires chased and scored?
• How is a DNA recorded, and what does the rebooking flow look like?
• If AI drafts anything, how does a clinician verify each claim against the underlying evidence, and what happens when they disagree with it?

Then run the compliance checks, which in the UK are pleasingly concrete:

• DTAC: NHS England's assessment criteria spanning clinical safety, data protection, technical security, interoperability and usability. Ask for the vendor's completed evidence, not a promise of readiness.
• DCB0129: the clinical risk management standard for health IT manufacturers. Ask for the clinical safety case, hazard log and the named Clinical Safety Officer.
• DSPT: the NHS Data Security and Protection Toolkit self-assessment. Look the vendor up on the public register rather than taking the badge on the website at face value.
• Security: Cyber Essentials Plus, independent penetration testing and GDPR posture. If the product drafts clinical content, ask about MHRA/UKCA medical device registration and what class it holds.

Ask for those artefacts by name, because the answers differ sharply by category and "we follow NHS guidelines" is not one. Among the practice-management platforms, Semble is ISO 27001 certified and Pabau lists Cyber Essentials, but none of Semble, Pabau, Cliniko or WriteUpp publishes a DCB0129 clinical safety case, a completed DTAC or a DSPT entry. The AI scribes are the exception, and they set the bar: Heidi and Accurx Scribe both publish DCB0129 documentation with named Clinical Safety Officers, DTAC evidence and DSPT entries, and both are MHRA-registered as Class I devices. Cerebric publishes the same stack — UKCA Class I registration, DTAC, DSPT at Standards Exceeded and a DCB0129 safety case. This matters beyond box-ticking: for any NHS-commissioned work, Right to Choose or block contract, the deploying organisation cannot complete its own DCB0160 assessment without the manufacturer's safety case.

The practical takeaway

Match the tool to the shape of the service. Multi-specialty clinic: a generalist platform like Semble or Pabau. Small allied health or therapy-led practice on a budget: Cliniko or WriteUpp, as long as no-frills suits you. Documentation pain only, in short consultations: a scribe such as Heidi Health or Accurx Scribe. Low volume: spreadsheets, honestly, are fine for now. A UK assessment service that wants the whole pathway governed in one place, on whatever mix of private, Right to Choose and block-contract funding it runs: Cerebric. Whatever you shortlist, demo it against your own pathway, demand DTAC, DCB0129 and DSPT evidence, and agree the exit terms before you sign.